SCHEMBL5203045

SCHEMBL5203045

Cc1c(N=C2NCCN2)cccc1NS(C)(=O)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.51
NFE2L2 Q16236 1/20 0.51
GAA P10253 1/20 0.40
NR3C1 P04150 8/20 0.40
PGR P06401 2/20 0.40
NR3C2 P08235 2/20 0.40
AR P10275 2/20 0.40
GLO1 Q04760 2/20 0.39
ALOX15 P16050 1/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TP53 P04637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PTGS1 P23219 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5205970 0.81 NR3C1 (0.40) KEAP1NFE2L2GAANR3C1PGR
SCHEMBL5201879 0.80 KEAP1 (0.46) KEAP1NFE2L2GAANR3C1PGR
SCHEMBL5201883 0.80 KEAP1 (0.46) KEAP1NFE2L2GAANR3C1PGR
SCHEMBL5203309 0.78 CHUK (0.38) KEAP1NFE2L2NR3C1PGRNR3C2
SCHEMBL5203701 0.78 SLC22A12 (0.35) KEAP1NFE2L2NR3C1PTGS1PTGS2
SCHEMBL8547039 0.76 L3MBTL1 (0.33) KEAP1NFE2L2NR3C1L3MBTL1
SCHEMBL8623385 0.73 MAPT (0.39) NPC1RAB9ATP53L3MBTL1HPGD
SCHEMBL5206710 0.71 MAPT (0.39) KEAP1NFE2L2NPC1RAB9AKDM4E
SCHEMBL5200692 0.71 KEAP1 (0.41) KEAP1NFE2L2NR3C1PTGS1PTGS2
SCHEMBL8626163 0.71 TAAR1 (0.36) GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 EP claimed
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 US disclosed
US-5952362-A INHIBITOR OF GLYCOGEN PHOSPHORYLASE ENZYMETIC ACTIVITY AND GLUCOSE ACITIVITY SYNTEX (U.S.A) INC. (US) 1999-09-14 US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 EP disclosed
EP-0838453-A1 HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME Eisai Co., Ltd. (JP) 1998-04-29 EP disclosed